What is Epitope Diagnostics?
Epitope Diagnostics Inc. is a certified medical device manufacturer based in San Diego, California, with a specialization in niche immunoassays. The company is recognized for its high-quality diagnostic solutions, including ELISA kits, rapid tests, and antibodies, catering to professional laboratories in fields such as oncology, infectious diseases, and autoimmune disorders. Holding ISO13485:2016 certification and US FDA registration, Epitope Diagnostics is committed to delivering reliable testing solutions for the global clinical diagnostics and research communities, aiming to advance medical understanding and patient care through innovative diagnostic tools.
How much funding has Epitope Diagnostics raised?
Epitope Diagnostics has raised a total of $1.5M across 1 funding round:
Debt
$1.5M
Debt (2024): $1.5M with participation from Bank of America
Key Investors in Epitope Diagnostics
Bank of America
Bank of America is a leading global financial institution providing a wide range of banking and financial services. Their involvement suggests a strong belief in Epitope Diagnostics' financial stability and growth potential, likely providing debt financing to support the company's operational scaling and strategic initiatives.
What's next for Epitope Diagnostics?
With the recent major strategic investment, Epitope Diagnostics is poised to accelerate its growth trajectory. This backing is expected to fuel further research and development into novel immunoassay technologies, potentially expanding its product portfolio and market reach. The company's focus on critical medical areas suggests that future capital deployment will likely target enhancing manufacturing capabilities, broadening its regulatory approvals, and strengthening its global distribution network to meet the increasing demand for advanced diagnostic solutions.
See full Epitope Diagnostics company page
